First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report)’s stock price fell 0.3% during mid-day trading on Tuesday . The company traded as low as GBX 1,670.10 ($21.16) and last traded at GBX 1,670.10 ($21.16). 20 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 1,708 shares. The stock had previously closed at GBX 1,675.70 ($21.23).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance
The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The company has a fifty day moving average price of GBX 1,616.17 and a two-hundred day moving average price of GBX 1,553.68. The firm has a market cap of £4.93 billion and a P/E ratio of -1,518.27.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Why Invest in 5G? How to Invest in 5G Stocks
- Netflix Is On Track To Hit $1,000 By Christmas
- 3 Warren Buffett Stocks to Buy Now
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.